1293286-23-3

Usage

Structure

Derivative of benzoic acid with a methoxy group (-OCH3) and a 1,2,3-triazole ring attached to the benzene ring

Utility

Widely utilized in pharmaceutical research and drug discovery

Biological Activities

Studied for its anti-inflammatory, antimicrobial, and anticancer properties

Applications

Used in the synthesis of various biologically active compounds
Employed as a building block for the development of new drugs

Significance

Valuable compound for further research and development due to its unique chemical structure and potential therapeutic properties.

Upstream product

• 67-56-1 methanol 
• 1293285-09-2 3-fluoro-2-(1H-1,2,3-triazol-1-yl)benzonitrile 

Relevant academic research and scientific papers

Monoacylglycerol Lipase Modulators

Bridged compounds of Formula (I) and Formula (II), pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with MGL modulation, such as those associated with pain, psychiatric disorders, neurological disorders (including, but not limited to major depressive disorder, treatment resistant depression, anxious depression, bipolar disorder), cancers and eye conditions. wherein R2, R3 R4, R5 and R6 are defined herein.

FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS

Certain disubstituted 3,8-diaza-bicyclo[4.2.0]octane and 3,6-diazabicyclo [3.2.0]heptane are described, which are useful as orexin inhibitors. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.